NDC 42291-496
Lithium Carbonate ER
Lithium Carbonate
Lithium Carbonate ER is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Avkare. The primary component is Lithium Carbonate.
| Product ID | 42291-496_d8ddff4d-2b78-a8f2-e053-2a95a90a5fc0 |
| NDC | 42291-496 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lithium Carbonate ER |
| Generic Name | Lithium Carbonate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-02-25 |
| Marketing Category | ANDA / |
| Application Number | ANDA091616 |
| Labeler Name | AvKARE |
| Substance Name | LITHIUM CARBONATE |
| Active Ingredient Strength | 450 mg/1 |
| Pharm Classes | Mood Stabilizer [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |